IMDA (Irish Medical Devices Association) hosts high-profile diagnostics forum:
This article was originally published in Clinica
Executive Summary
The Irish Medical Devices Association (IMDA) last week hosted a forum of chief executives from the association's nine member diagnostics companies. John Place, director-general of the European Diagnostics Manufacturers Association (EDMA), was the keynote speaker at the event. The meeting, held in Dublin on January 23, is the first of what is set to become a regular once or twice-yearly event, addressing European and global trends in the diagnostics market, funding opportunities and issues, and training initiatives. Details of developments to emerge from the meeting were not available as Clinica went to press (see next issue).
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.